Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 4/20 | 0.56 |
| ▸ | CES1 | P23141 | 4/20 | 0.56 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.54 |
| ▸ | PPARG | P37231 | 7/20 | 0.54 |
| ▸ | PPARD | Q03181 | 7/20 | 0.54 |
| ▸ | PPARA | Q07869 | 7/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.54 |
| ▸ | TSHR | P16473 | 5/20 | 0.54 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | TLR2 | O60603 | 2/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | FABP4 | P15090 | 2/20 | 0.54 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.54 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | ESR1 | P03372 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | PDE4A | P27815 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27839324 | 1.00 | CES2 (0.56) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL28614140 | 1.00 | CES2 (0.56) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL16100284 | 1.00 | CES2 (0.56) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL8443919 | 1.00 | CES2 (0.56) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL1562757 | 1.00 | CES2 (0.56) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL3172758 | 1.00 | CES2 (0.56) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL10530967 | 1.00 | CES2 (0.56) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL6536571 | 1.00 | CES2 (0.56) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL3134715 | 1.00 | CES2 (0.56) | CES2CES1GPR84PPARGPPARD | |
| SCHEMBL28192658 | 1.00 | CES2 (0.56) | CES2CES1GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3313370-B1 | OPHTHALMOLOGIC PHARMACEUTICAL COMPOSITION | CONTIPRO AS (CZ) | 2020-12-30 | — | — | EP | claimed |
| US-20180296473-A1 | Ophthalmologic Pharmaceutical Composition | CONTIPRO A.S. (CZ) | 2018-10-18 | — | — | US | claimed |
| EP-3313370-A1 | OPHTHALMOLOGIC PHARMACEUTICAL COMPOSITION | Contipro A.S. (CZ) | 2018-05-02 | — | — | EP | claimed |
| WO-2016207340-A1 | OPHTHALMOLOGIC PHARMACEUTICAL COMPOSITION | TRB CHEMEDICA AG (DE) | 2016-12-29 | — | — | WO | claimed |
| EP-3108874-A1 | OPHTHALMOLOGIC PHARMACEUTICAL COMPOSITION | TRB Chemedica AG (DE) | 2016-12-28 | — | — | EP | claimed |
| CN-113376965-B | Coloring composition and compound | 住友化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-113376962-B | Coloring composition and compound | 住友化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-113376963-B | Coloring composition and compound | 住友化学株式会社 | 2024-05-28 | — | — | CN | disclosed |
| CN-113376964-B | Coloring composition and compound | 住友化学株式会社 | 2024-04-26 | — | — | CN | disclosed |
| CN-107797382-B | Coloring composition | 住友化学株式会社 | 2022-02-22 | — | — | CN | disclosed |
| CN-107797381-B | Coloring composition and compound | 住友化学株式会社 | 2022-02-18 | — | — | CN | disclosed |
| CN-113376962-A | Coloring composition and compound | 住友化学株式会社 | 2021-09-10 | — | — | CN | disclosed |
| CN-107797382-A | Coloured composition | 住友化学株式会社 | 2018-03-13 | — | — | CN | disclosed |
| CN-107586469-A | Color compositions, coloured composition and cured composition for color | 住友化学株式会社 | 2018-01-16 | — | — | CN | disclosed |
| WO-2016207340-A1 | OPHTHALMOLOGIC PHARMACEUTICAL COMPOSITION | TRB CHEMEDICA AG (DE) | 2016-12-29 | — | — | WO | disclosed |
| EP-3108874-A1 | OPHTHALMOLOGIC PHARMACEUTICAL COMPOSITION | TRB Chemedica AG (DE) | 2016-12-28 | — | — | EP | disclosed |
| US-20090240044-A1 | PROCESS FOR THE REDUCTION OF ENDOTOXINS IN A PLASMID PREPARATION USING A CARBOHYDRATE NON-IONIC DETERGENT WITH SILICA CHROMATOGRAPHY | SIGMA-ALDRICH COMPANY (US) | 2009-09-24 | — | — | US | disclosed |
| US-7531308-B2 | Process for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography | SIGMA-ALDRICH CO. (US) | 2009-05-12 | — | — | US | disclosed |
| WO-2005111059-A2 | PROCESS FOR THE REDUCTION OF ENDOTOXINS | SIGMA-ALDRICH CO. (US) | 2005-11-24 | — | — | WO | disclosed |
| US-20050245733-A1 | Process for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography | SIGMA-ALDRICH CO. | 2005-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090240044-A1 | PROCESS FOR THE REDUCTION OF ENDOTOXINS IN A PLASMID PREPARATION USING A CARBOHYDRATE NON-IONIC DETERGENT WITH SILICA CHROMATOGRAPHY | SI, DDOST, LITAF | CES2 2658/4885CES1 806/4885GPR84 3971/4885 |
| US-20180296473-A1 | Ophthalmologic Pharmaceutical Composition | UACA, MYOC, WDR36 | CES2 4744/4885CES1 1331/4885GPR84 3247/4885 |
| US-20050245733-A1 | Process for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography | SI, DDOST, LITAF | CES2 2658/4885CES1 806/4885GPR84 3971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.